in order to gather information on the role of hyperinsulinemia and glucose intolerance in the development of the above lipid metabolism abnormalities , diazoxide , a known insulin release blocking agent was administered ( 120 mg/kg/day ) together with the diet ( srd + dzx ) for 22 days .
C0598783
lipid metabolism
C0021641
insulin